Guardant Health Overview
Guardant Health Target Price
Analysts' 12-month price predictions for GH.
Get informed when a big investor buys or sells
+ FollowShare Price
$136.96
Average Target Price
$153.00
11.7% upside
11.7% upside9 analysts in the last 4 months
High: $185 | Low: $115
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-11 | RBC CapitalDan Leonard | $185 | 35.1% upside |  |
| 2026-06-08 | Mizuho Securities | $175 | 27.8% upside | |
| 2026-06-05 | Goldman SachsEvie Koslosky | $165 | 20.5% upside | |
| 2026-06-02 | Evercore ISI | $160 | 16.8% upside | |
| 2026-05-27 | BTIG | $160 | 16.8% upside | |
| 2026-05-26 | BTIGMark Massaro | $155 | 13.2% upside | |
| 2026-05-21 | Piper Sandler | $127 |  7.3% downside | |
| 2026-05-12 | Piper SandlerDavid Westenberg | $135 | 1.4% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $115 | 16% downside | |
| 2026-02-24 | Piper Sandler | $130 | 5.1% downside | |
| 2026-02-23 | Raymond James | $129 | 5.8% downside | |
| 2026-02-20 | Evercore ISI | $110 | 19.7% downside | |
| 2026-02-20 | BTIG | $145 | 5.9% upside | |
| 2026-02-20 | Stifel Nicolaus | $130 | 5.1% downside | |
| 2026-02-20 | Canaccord Genuity | $135 | 1.4% downside | |
| 2026-02-20 | Barclays | $130 | 5.1% downside | |
| 2026-02-17 | Robert W. BairdCatherine Schulte | $120 | 12.4% downside | |
| 2026-01-30 | UBS | $175 | 27.8% upside | |
| 2026-01-26 | Guggenheim | $135 | 1.4% downside | |
| 2026-01-09 | Stifel Nicolaus | $120 | 12.4% downside | |
| 2026-01-09 | Mizuho Securities | $135 | 1.4% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $115 | 16% downside | |
| 2026-01-05 | Evercore ISIVijay Kumar | $105 | 23.3% downside | |
| 2025-12-22 | Canaccord Genuity | $125 | 8.7% downside | |
| 2025-12-17 | Mizuho Securities | $120 | 12.4% downside | |
| 2025-12-15 | Leerink Partners | $155 | 13.2% upside | |
| 2025-12-15 | Wells FargoBrandon Couillard | $120 | 12.4% downside | |
| 2025-12-15 | Barclays | $120 | 12.4% downside | |
| 2025-12-12 | BTIG | $140 | 2.2% upside | |
| 2025-12-01 | Morgan StanleyTejas Savant | $130 | 5.1% downside | |
| 2025-10-30 | UBSDan Leonard | $110 | 19.7% downside | |
| 2025-10-30 | BTIGMark Massaro | $100 | 27% downside | |
| 2025-10-30 | Mizuho SecuritiesBradley Bowers | $100 | 27% downside | |
| 2025-10-30 | Canaccord GenuityKyle Mikson | $100 | 27% downside | |
| 2025-10-30 | Barclays | $85 | 37.9% downside | |
| 2025-10-22 | Piper Sandler | $90 | 34.3% downside | |
| 2025-10-02 | Barclays | $70 | 48.9% downside | |
| 2025-09-26 | Canaccord GenuityKyle Mikson | $75 | 45.2% downside | |
| 2025-09-25 | Stifel Nicolaus | $70 | 48.9% downside | |
| 2025-09-25 | BTIGMark Massaro | $80 | 41.6% downside | |
| 2025-09-25 | Stifel NicolausDaniel Arias | $73 | 46.7% downside | |
| 2025-09-25 | Wolfe ResearchDoug Schenkel | $75 | 45.2% downside | |
| 2025-06-25 | China Renaissance Securities (US) Inc.Tempus AI | $70 | 48.9% downside | |
| 2025-03-05 | Morgan Stanley | $52 | 62% downside | |
| 2024-08-21 | UBSDan Leonard | $40 | 70.8% downside | |
| 2024-08-08 | Craig-HallumBill Bonello | $37 | 73% downside | |
| 2024-08-08 | JefferiesTycho Peterson | $40 | 70.8% downside | |
| 2024-07-29 | BTIGMark Massaro | $50 | 63.5% downside | |
| 2024-06-28 | GuggenheimSubbu Nambi | $36 | 73.7% downside | |
| 2024-06-04 | Canaccord GenuityKyle Mikson | $38 | 72.3% downside | |